Leicester, United Kingdom

Lawrence Hylton Patterson


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Leicester LE3 7AH, GB (2002)
  • Leicester, GB (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Lawrence Hylton Patterson**

Introduction

Lawrence Hylton Patterson, based in Leicester, GB, is an accomplished inventor known for his contributions to the field of pharmaceutical sciences. With a total of three patents to his name, Patterson focuses primarily on prodrugs that leverage enzymatic activation mechanisms for drug release. His work is notably significant in the context of anti-tumor therapies, making strides in the advancement of targeted medical treatments.

Latest Patents

Patterson's latest patents reflect his commitment to innovative drug development. The first patent, titled "Hydroxylation Activated Drug Release," introduces prodrugs that become activated through their aromatic oxidation, particularly via enzymatic aromatic hydroxylation. This process allows for the release of a drug moiety, with specific applications in anti-tumor prodrugs activated by the P-450 enzyme CYP1B1. Furthermore, he has established methods for detecting aromatic oxidation activity, enhancing the understanding and monitoring of drug activation mechanisms.

His second patent, "Hydroxylation Activated Prodrugs," continues this theme by focusing on enzymatic activation. It highlights the significance of anti-tumor prodrugs that specifically rely on the hydroxylation activity of the CYP1B1 enzyme. This targeted approach not only enhances therapeutic efficacy but also minimizes potential side effects, showcasing Patterson's innovative prowess in drug design.

Career Highlights

Throughout his career, Lawrence Hylton Patterson has been associated with notable institutions such as De Montfort University, where he has significantly contributed to research and development in pharmacology. His expertise has propelled advancements in the creation of prodrugs that address serious health challenges, particularly in cancer treatment.

Collaborations

Patterson has collaborated with distinguished professionals in his field, including Michael Danny Burke and Gerard Andrew Potter. These partnerships have fostered an environment of innovation and have amplified the impact of their collective research efforts in the development of novel therapeutic strategies.

Conclusion

Lawrence Hylton Patterson stands out as a notable inventor in the realm of pharmaceutical innovation. His patents reflect a deep understanding of enzymatic processes and their application in drug development, particularly for anti-tumor therapies. With a solid foundation in research and collaboration, Patterson continues to contribute to significant advancements in medicine, paving the way for more effective treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…